An intelligence-led doping test was carried out by the CADF in collaboration with the AFLD (Agence Française de Lutte contre le Dopage) and the OCLAEPS (Office Central de Lutte contre les Atteintes à l‘Environnement et la Santé Publique) on March the 8th 2018 on the French Rider Rémy Di Gregorio during the UCI WorldTour race Paris-Nice. The test returned an Adverse Analytical Finding (AAF) for Darbepoetin (dEPO)*. The rider was provisionally suspended by the UCI (Union Cycliste Internationale) and a press release was published on the UCI website (http://www.uci.ch/pressreleases/uci-statement-remy-gregorio/) * dEPO is classified as “Peptide Hormones, Growth Factors, Related Substances and Mimetics” as per the World Anti-Doping Prohibited List.”
To Riders and Support Personnel The 2018 Prohibited List comes into effect on 1 January 2018. It is highly recommended that all Riders and Support Staff take the time to familiarize themselves with this important information. (Several languages below)
The CADF Foundation is delighted to announce the appointment of Rune Andersen as Chairman of its Board of directors.
Anti-Doping Norway (ADNO) and the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the Union Cycliste Internationale (UCI) to define and carry out the fight against doping in cycling, are delighted to confirm that they will closely collaborate on anti-doping controls during the 2017 UCI Road World Championships, which begin on 16 September 2017 in Bergen, Norway.
It is with great sadness that we announce the death of Dr George Ruijsch van Dugteren, the CADF President.
Do you know how many anti-doping controls were carried out by CADF in 2016? Do you know which disciplines were tested? Do you know how anti-doping in cycling is financed? Check out the CADF 2016 Business Report here.
The Agence Française de Lutte contre le Dopage (AFLD) and the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the Union Cycliste Internationale (UCI) to define and carry out the fight against doping in cycling, confirmed today that they will continue their close collaboration on anti-doping controls during the 2017 Tour De France, which begins on Saturday 1st July in Düsseldorf, Germany.
The CADF Funding Committee was held in Geneva on June 14th 2017 with the presence of the cycling stakeholders’ representatives.
The Testing Manager collaborates with the CADF Team to coordinate the overall CADF testing activities.
Welcome to the Cycling Anti-Doping Foundation (CADF) website !